TRPM7 and melanoma: The pharmacological inhibition of TRPM7 using compounds such as waixenicin A or NS8593 has been shown to exert anti-proliferative and anti-metastatic effects not only in melanoma but also in other malignancies, underlining its potential as a broad-spectrum therapeutic target [70].